Congenital Thrombotic Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Congenital Thrombotic Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS approval · 2025-02-24Clinical Trial Update: Expanded Access Program of TAK-755 for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Takeda's TAK-755 expanded access program for congenital thrombotic thrombocytopenic purpura has been approved for marketing, enabling broade…